Models that combine transcriptomic with spatial protein information exceed the predictive value for either single modality.

Publication date: May 28, 2021

Open Access PDF

Concepts Keywords
Diagnostic Molecular biology
Immunohistochemistry Branches of biology
Melanoma Immunotherapy
Pcr Melanoma
Therapeutics Omics
Transcriptomic Anatomical pathology
Tumor Laboratory techniques
Transcriptomics technologies


Type Source Name
drug DRUGBANK Trestolone
drug DRUGBANK Coenzyme M
disease MESH Pathology
drug DRUGBANK Myricetin
drug DRUGBANK Ipilimumab
drug DRUGBANK Pembrolizumab
drug DRUGBANK Nivolumab
drug DRUGBANK Formaldehyde
pathway KEGG Melanoma
disease MESH melanoma
disease MESH microsatellite instability
pathway KEGG Mismatch repair
disease MESH death
disease MESH cancer
drug DRUGBANK Saquinavir
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Aspartame
disease MESH Uveal melanoma
disease MESH uncertainty
disease MESH privacy
disease MESH lung cancer
disease MESH Growth
disease MESH breast cancer
pathway KEGG Breast cancer
drug DRUGBANK Trastuzumab
drug DRUGBANK Cyclic Adenosine Monophosphate
drug DRUGBANK Etoperidone

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *